If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
OCTREOTIDE GH octreotide as acetate 100 micrograms/1 mL injection ampoule AUST R: 148402Active ingredients:
octreotide
Dosage form:
Injection, solution
Sponsor:
Generic Health Pty Ltd
Phone:
03 9809 7936
|
From
19 Dec 2023
to
31 May 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
|
OCTREOTIDE GH octreotide as acetate 50 micrograms/1 mL injection ampoule AUST R: 148404Active ingredients:
octreotide
Dosage form:
Injection, solution
Sponsor:
Generic Health Pty Ltd
Phone:
03 9809 7922
|
From
06 May 2024
to
31 May 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
|
OCTREOTIDE GH octreotide as acetate 500 micrograms/1 mL injection ampoule AUST R: 148403Active ingredients:
octreotide
Dosage form:
Injection, solution
Sponsor:
Generic Health Pty Ltd
Phone:
03 9809 7936
|
From
25 Mar 2024
to
31 May 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
|
SANDOSTATIN Octreotide 50 microgram/1mL injection ampoule AUST R: 42192Active ingredients:
octreotide
Dosage form:
Injection, solution
Sponsor:
Novartis Pharmaceuticals Australia Pty Ltd
Phone:
1800635202
|
From
23 May 2024
to
29 Oct 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
OCTREOTIDE DEPOT octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack AUST R: 321280Active ingredients:
octreotide
Dosage form:
Injection, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
15 Dec 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic product is available.
|
OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack AUST R: 321282Active ingredients:
octreotide
Dosage form:
Injection, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
15 Dec 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic product is available.
|
OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack AUST R: 321281Active ingredients:
octreotide
Dosage form:
Injection, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
15 Dec 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic product is available.
|